Neurocrine Biosciences shares owned by EFG Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by EFG Asset Management
from 13F filings
Historical chart of EFG Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by EFG Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by EFG Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.3M | 9.3k | 140.27 |
| 2025-06-30 | $1.4M | 11k | 125.68 |
| 2025-03-31 | $1.1M | 10k | 110.59 |
| 2024-12-31 | $1.8M | 13k | 136.58 |
| 2024-09-30 | $3.2M | 28k | 115.16 |
| 2024-06-30 | $4.6M | 33k | 137.67 |
| 2024-03-31 | $4.9M | 36k | 137.83 |
| 2023-12-31 | $4.8M | 37k | 131.82 |
| 2023-09-30 | $4.3M | 38k | 112.52 |
| 2023-06-30 | $3.6M | 38k | 94.27 |
| 2023-03-31 | $3.4M | 34k | 101.25 |
| 2022-12-31 | $3.5M | 30k | 120.20 |
| 2022-09-30 | $3.3M | 31k | 106.20 |
| 2022-06-30 | $3.3M | 33k | 97.51 |
| 2022-03-31 | $2.9M | 31k | 93.78 |